Clinical Trial Update: Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the effects of propofol and desflurane on nucleic acids of liver circulating tumor cells in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DESFLURANE (DESFLURANE)
• PROPOFOL (Propofol)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Hepatocellular Carcinoma, Desflurane Adverse Reaction | Phase 2 | Status: COMPLETED